Polymorphisms of microRNA Sequences or Binding Sites and Lung Cancer: A Meta-Analysis and Systematic Review

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Chen, Zhiwei ^a   Xu, Ling ^b   Ye, Xiangyun ^a   Shen, Shengping ^a   Li, Ziming ^a   Niu, Xiaomin ^a   Lu, Shun ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 146A; MICRORNA 149; MICRORNA 196A; MICRORNA 499; MICRORNA 605; TUMOR MARKER; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; CANCER GRADING; CANCER RISK; CANCER SURVIVAL; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; HOMOZYGOSITY; HUMAN; LUNG CANCER; QUANTITATIVE ANALYSIS; RNA SEQUENCE; SINGLE NUCLEOTIDE POLYMORPHISM; SURVIVAL RATE; SYSTEMATIC REVIEW;

BINDING SITES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LUNG NEOPLASMS; MICRORNAS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84876170920     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0061008     Document Type: Article

References (37)

1. Jemal A, Siegel R, Xu J, Ward E, (2010) Cancer statistics, 2010. CA Cancer J Clin 60: 277-300.
2. Kiyohara C, Horiuchi T, Takayama K, Nakanishi Y, (2012) Genetic polymorphisms involved in carcinogen metabolism and DNA repair and lung cancer risk in a Japanese population. J Thorac Oncol 7: 954-962.
3. Lopez-Cima MF, Gonzalez-Arriaga P, Garcia-Castro L, Pascual T, Marron MG, et al. (2007) Polymorphisms in XPC, XPD, XRCC1, and XRCC3 DNA repair genes and lung cancer risk in a population of northern Spain. BMC Cancer 7: 162.
4. Hong YS, Kang HJ, Kwak JY, Park BL, You CH, et al. (2011) Association between microRNA196a2 rs11614913 genotypes and the risk of non-small cell lung cancer in Korean population. J Prev Med Public Health 44: 125-130.
5. Kim MJ, Yoo SS, Choi YY, Park JY, (2010) A functional polymorphism in the pre-microRNA-196a2 and the risk of lung cancer in a Korean population. Lung Cancer 69: 127-129.
6. Tian T, Shu Y, Chen J, Hu Z, Xu L, et al. (2009) A functional genetic variant in microRNA-196a2 is associated with increased susceptibility of lung cancer in Chinese. Cancer Epidemiol Biomarkers Prev 18: 1183-1187.
7. Zhang MW, Yu YX, Jin MJ, Pan YF, Jiang X, et al. (2011) [Association of miR-605 and miR-149 genetic polymorphisms with related risk factors of lung cancer susceptibility]. Zhejiang Da Xue Xue Bao Yi Xue Ban 40: 265-271.
8. Bartel DP, (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
9. Mendell JT, (2005) MicroRNAs: critical regulators of development, cellular physiology and malignancy. Cell Cycle 4: 1179-1184.
10. Valencia-Sanchez MA, Liu J, Hannon GJ, Parker R, (2006) Control of translation and mRNA degradation by miRNAs and siRNAs. Genes Dev 20: 515-524.
11. Ambros V, (2004) The functions of animal microRNAs. Nature 431: 350-355.
12. Aumiller V, Forstemann K, (2008) Roles of microRNAs beyond development-metabolism and neural plasticity. Biochim Biophys Acta 1779: 692-696.
13. Gregory RI, Shiekhattar R, (2005) MicroRNA biogenesis and cancer. Cancer Res 65: 3509-3512.
14. Johnnidis JB, Harris MH, Wheeler RT, Stehling-Sun S, Lam MH, et al. (2008) Regulation of progenitor cell proliferation and granulocyte function by microRNA-223. Nature 451: 1125-1129.
15. Lewis BP, Burge CB, Bartel DP, (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15-20.
16. Krek A, Grun D, Poy MN, Wolf R, Rosenberg L, et al. (2005) Combinatorial microRNA target predictions. Nat Genet 37: 495-500.
17. Wang Z, Cao Y, Jiang C, Yang G, Wu J, et al. (2012) Lack of association of two common polymorphisms rs2910164 and rs11614913 with susceptibility to hepatocellular carcinoma: a meta-analysis. PLoS One 7: e40039.
18. Qiu MT, Hu JW, Ding XX, Yang X, Zhang Z, et al. (2012) Hsa-miR-499 rs3746444 polymorphism contributes to cancer risk: a meta-analysis of 12 studies. PLoS One 7: e50887.
19. Guo J, Jin M, Zhang M, Chen K, (2012) A genetic variant in miR-196a2 increased digestive system cancer risks: a meta-analysis of 15 case-control studies. PLoS One 7: e30585.
20. Chin LJ, Ratner E, Leng S, Zhai R, Nallur S, et al. (2008) A SNP in a let-7 microRNA complementary site in the KRAS 3′ untranslated region increases non-small cell lung cancer risk. Cancer Res 68: 8535-8540.
21. Nelson HH, Christensen BC, Plaza SL, Wiencke JK, Marsit CJ, et al. (2010) KRAS mutation, KRAS-LCS6 polymorphism, and non-small cell lung cancer. Lung Cancer 69: 51-53.
22. Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR, (2007) Practical methods for incorporating summary time-to-event data into meta-analysis. Trials 8: 16.
23. Wu J, Liu J, Zhou Y, Ying J, Zou H, et al. (2012) Predictive value of XRCC1 gene polymorphisms on platinum-based chemotherapy in advanced non-small cell lung cancer patients: a systematic review and meta-analysis. Clin Cancer Res 18: 3972-3981.
24. Lau J, Ioannidis JP, Schmid CH, (1997) Quantitative synthesis in systematic reviews. Ann Intern Med 127: 820-826.
25. Egger M, Davey Smith G, Schneider M, Minder C, (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-634.
26. Hu Z, Zhao Y, Tian T, Liang J, Jin G, et al. (2009) Association between microRNA polymorphisms, expressions, lung cancer development and prognosis. Biomedicine and Pharmacotherapy 63: 323.
27. Vinci S, Gelmini S, Pratesi N, Conti S, Malentacchi F, et al. (2011) Genetic variants in miR-146a, miR-149, miR-196a2, miR-499 and their influence on relative expression in lung cancers. Clin Chem Lab Med 49: 2073-2080.
28. Zhan X, Wu W, Han B, Gao G, Qiao R, et al. (2012) Hsa-miR-196a2 functional SNP is associated with severe toxicity after platinum-based chemotherapy of advanced nonsmall cell lung cancer patients in a Chinese population. J Clin Lab Anal 26: 441-446.
29. Campayo M, Navarro A, Vinolas N, Tejero R, Munoz C, et al. (2011) A dual role for KRT81: a miR-SNP associated with recurrence in non-small-cell lung cancer and a novel marker of squamous cell lung carcinoma. PLoS One 6: e22509.
30. Ding C, Li R, Peng J, Li S, Guo Z, (2012) A polymorphism at the miR-502 binding site in the 3′ untranslated region of the SET8 gene is associated with the outcome of small-cell lung cancer. Exp Ther Med 3: 689-692.
31. Hu Z, Chen J, Tian T, Zhou X, Gu H, et al. (2008) Genetic variants of miRNA sequences and non-small cell lung cancer survival. J Clin Invest 118: 2600-2608.
32. Hu Z, Shu Y, Chen Y, Chen J, Dong J, et al. (2011) Genetic polymorphisms in the precursor MicroRNA flanking region and non-small cell lung cancer survival. Am J Respir Crit Care Med 183: 641-648.
33. Xiong F, Wu C, Chang J, Yu D, Xu B, et al. (2011) Genetic variation in an miRNA-1827 binding site in MYCL1 alters susceptibility to small-cell lung cancer. Cancer Res 71: 5175-5181.
34. Yang L, Li Y, Cheng M, Huang D, Zheng J, et al. (2012) A functional polymorphism at microRNA-629-binding site in the 3′-untranslated region of NBS1 gene confers an increased risk of lung cancer in Southern and Eastern Chinese population. Carcinogenesis 33: 338-347.
35. Yoon KA, Yoon H, Park S, Jang HJ, Zo JI, et al. (2012) The prognostic impact of microRNA sequence polymorphisms on the recurrence of patients with completely resected non-small cell lung cancer. J Thorac Cardiovasc Surg 144: 794-807.
36. Zhang S, Chen H, Zhao X, Cao J, Tong J, et al. (2013) REV3L 3′UTR 460 T>C polymorphism in microRNA target sites contributes to lung cancer susceptibility. Oncogene 32: 242-250.
37. Shi X, Kachirskaia I, Yamaguchi H, West LE, Wen H, et al. (2007) Modulation of p53 function by SET8-mediated methylation at lysine 382. Mol Cell 27: 636-646.